GSK3 inhibitor suppresses cell growth and metabolic process in FLT3-ITD leukemia cells

Glycogen Synthase Kinase-3 (GSK-3) was recently implicated in the dysregulated biology of acute myeloid leukemia (AML). Low concentrations of GSK-3 inhibitors, SB216763 and BIO, suppressed the proliferation of AML cells with FLT3-ITD as early as 24 h after treatment. BIO was used in subsequent assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jing, Feng, Shuxian, Zhou, Jian, Zhang, Lin, Shi, Dingfang, Wang, Mengjie, Zhu, Yi, Bu, Chaozhi, Xu, Daming, Li, Tianyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732066/
https://www.ncbi.nlm.nih.gov/pubmed/36481875
http://dx.doi.org/10.1007/s12032-022-01899-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732066/
https://www.ncbi.nlm.nih.gov/pubmed/36481875
http://dx.doi.org/10.1007/s12032-022-01899-2

Ejemplares similares